INTUITIVE SURGICAL INC 8-K

What Happened
Intuitive Surgical filed a Form 8-K on May 28, 2026, announcing an executive role change effective July 1, 2026. Henry L. Charlton will transition from his current role as Chief Commercial and Marketing Officer to Senior Vice President of Global Business Operations. Taylor Patton, currently Global Senior Vice President, Endoluminal, will succeed Charlton as Chief Commercial and Marketing Officer.

Key Details

• Filing date: May 28, 2026; transition effective: July 1, 2026.
• Henry L. Charlton moves from Chief Commercial & Marketing Officer to Senior VP, Global Business Operations.
• Taylor Patton (Global SVP, Endoluminal) named Chief Commercial & Marketing Officer.
• Company press release announcing the changes is attached as Exhibit 99.1 to the 8-K.

Why It Matters
This is an internal leadership reorganization focused on commercial and global business operations. For investors, the filing signals continuity in Intuitive’s commercial leadership (a named successor) and a new assignment for Charlton that could affect global operations oversight. The 8-K does not report departures from the company, changes in executive compensation, or other material financial impacts.